Cargando…
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection
Hemodialysis patients are vulnerable to severe and lethal COVID-19, and their protective immunity against COVID-19 is not yet fully understood. Therefore, we report a case of COVID-19 reinfection in a hemodialysis patient 81 days after the first episode and discuss the role of antibodies in SARS-CoV...
Autores principales: | Beppu, Hiroko, Ogawa, Toshie, Ishikane, Masahiro, Kawanishi, Tomoko, Fukuda, Tatsuya, Sato, Lubuna, Matsunaga, Akihiro, Maeda, Kenji, Katagiri, Daisuke, Ishizaka, Yukihito, Mitsuya, Hiroaki, Ohmagari, Norio, Yasui, Fumihiko, Kohara, Michinori, Kikuchi, Kan, Wakai, Sachiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906520/ https://www.ncbi.nlm.nih.gov/pubmed/35266095 http://dx.doi.org/10.1007/s13730-022-00697-z |
Ejemplares similares
-
Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study
por: Otsubo, Naoya, et al.
Publicado: (2023) -
Hemodialysis patients with coronavirus disease 2019: reduced antibody response
por: Beppu, Hiroko, et al.
Publicado: (2021) -
Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection
por: Inada, Makoto, et al.
Publicado: (2022) -
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC(50)) of neutralizing antibodies
por: Inada, Makoto, et al.
Publicado: (2021) -
Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine
por: Miyazato, Yusuke, et al.
Publicado: (2022)